LAM
WST icon

LECAP Asset Management’s West Pharmaceutical WST Stock Holding History

LECAP Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,121
Closed -$782K – 392
2026
Q1 		$782K Buy
3,121
+867
+38% +$216K 0.29% 145
2025
Q4 		$620K Buy
+2,254
New +$617K 0.25% 153
2025
Q3 		– Sell
-1,481
Closed -$324K – 407
2025
Q2 		$324K Buy
+1,481
New +$317K 0.11% 253

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LECAP Asset Management's WST Position: Q2 2026 in Review

LECAP Asset Management sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 3,121 shares — an estimated $782K sold.

LECAP Asset Management first reported a position in WST in Q2 2025 and held it in 3 quarters. The position peaked at $782K in Q1 2026. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • LECAP Asset Management reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • LECAP Asset Management sold 3,121 West Pharmaceutical shares in Q2 2026, an estimated $782K.
  • LECAP Asset Management first reported a position in West Pharmaceutical in Q2 2025 and held it in 3 quarters.
  • LECAP Asset Management's West Pharmaceutical position peaked at $782K in Q1 2026.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.